Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SGN-2FF |
Synonyms | |
Therapy Description |
SGN-2FF is a fucose analog that inhibits protein fucosylation, potentially resulting in decreased tumor growth (PMID: 34288257). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SGN-2FF | SGN 2FF|SGN2FF | SGN-2FF is a fucose analog that inhibits protein fucosylation, potentially resulting in decreased tumor growth (PMID: 34288257). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02952989 | Phase I | SGN-2FF | A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors | Terminated | USA | 0 |